Annual Accounts Receivable
$206.56 M
+$27.42 M+15.31%
31 March 2024
Summary:
Haemonetics annual accounts receivable is currently $206.56 million, with the most recent change of +$27.42 million (+15.31%) on 31 March 2024. During the last 3 years, it has risen by +$79.01 million (+61.94%). HAE annual accounts receivable is now at all-time high.HAE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$213.53 M
+$12.05 M+5.98%
28 September 2024
Summary:
Haemonetics quarterly accounts receivable is currently $213.53 million, with the most recent change of +$12.05 million (+5.98%) on 28 September 2024. Over the past year, it has increased by +$39.28 million (+22.55%). HAE quarterly accounts receivable is now at all-time high.HAE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.3% | +22.6% |
| 3 y3 years | +61.9% | +37.8% |
| 5 y5 years | +11.6% | +21.0% |
HAE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +61.9% | at high | +51.1% |
| 5 y | 5 years | at high | +61.9% | at high | +67.4% |
| alltime | all time | at high | +249.3% | at high | +261.1% |
Haemonetics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $213.53 M(+6.0%) |
| June 2024 | - | $201.49 M(-2.5%) |
| Mar 2024 | $206.56 M(+15.3%) | - |
| Mar 2024 | - | $206.56 M(-2.4%) |
| Dec 2023 | - | $211.61 M(+21.4%) |
| Sept 2023 | - | $174.25 M(-1.6%) |
| June 2023 | - | $177.12 M(-1.1%) |
| Mar 2023 | $179.14 M(+12.4%) | $179.14 M(-1.1%) |
| Dec 2022 | - | $181.10 M(+5.6%) |
| Sept 2022 | - | $171.53 M(+17.1%) |
| June 2022 | - | $146.46 M(-8.1%) |
| Mar 2022 | $159.38 M(+24.9%) | $159.38 M(+2.8%) |
| Dec 2021 | - | $154.98 M(+9.7%) |
| Sept 2021 | - | $141.31 M(+6.3%) |
| June 2021 | - | $132.91 M(+4.2%) |
| Mar 2021 | $127.56 M(-22.8%) | $127.56 M(-13.2%) |
| Dec 2020 | - | $146.94 M(+3.8%) |
| Sept 2020 | - | $141.53 M(+0.3%) |
| June 2020 | - | $141.09 M(-14.6%) |
| Mar 2020 | $165.21 M(-10.7%) | $165.21 M(-3.2%) |
| Dec 2019 | - | $170.75 M(-3.3%) |
| Sept 2019 | - | $176.53 M(+8.1%) |
| June 2019 | - | $163.34 M(-11.7%) |
| Mar 2019 | $185.03 M(+22.4%) | $185.03 M(+10.4%) |
| Dec 2018 | - | $167.64 M(+3.7%) |
| Sept 2018 | - | $161.59 M(+6.8%) |
| June 2018 | - | $151.34 M(+0.1%) |
| Mar 2018 | $151.23 M(-1.0%) | $151.23 M(+3.1%) |
| Dec 2017 | - | $146.72 M(+2.1%) |
| Sept 2017 | - | $143.69 M(-5.2%) |
| June 2017 | - | $151.51 M(-0.8%) |
| Mar 2017 | $152.68 M(-2.8%) | $152.68 M(+1.4%) |
| Dec 2016 | - | $150.56 M(-0.7%) |
| Sept 2016 | - | $151.60 M(+1.3%) |
| June 2016 | - | $149.67 M(-4.7%) |
| Mar 2016 | $157.09 M(+7.7%) | $157.09 M(+5.6%) |
| Dec 2015 | - | $148.77 M(+2.3%) |
| Sept 2015 | - | $145.41 M(+4.5%) |
| June 2015 | - | $139.10 M(-4.6%) |
| Mar 2015 | $145.83 M(-11.4%) | $145.83 M(+1.5%) |
| Dec 2014 | - | $143.63 M(-4.9%) |
| Sept 2014 | - | $151.06 M(-3.6%) |
| June 2014 | - | $156.73 M(-4.8%) |
| Mar 2014 | $164.60 M(-3.2%) | $164.60 M(+10.0%) |
| Dec 2013 | - | $149.59 M(-7.7%) |
| Sept 2013 | - | $162.08 M(+3.9%) |
| June 2013 | - | $155.96 M(-8.3%) |
| Mar 2013 | $170.11 M | $170.11 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $167.35 M(+5.8%) |
| Sept 2012 | - | $158.18 M(+25.4%) |
| June 2012 | - | $126.13 M(-6.9%) |
| Mar 2012 | $135.46 M(+6.5%) | $135.46 M(+6.3%) |
| Dec 2011 | - | $127.44 M(-1.4%) |
| Sept 2011 | - | $129.24 M(+7.0%) |
| June 2011 | - | $120.76 M(-5.0%) |
| Mar 2011 | $127.17 M(+7.2%) | $127.17 M(+5.6%) |
| Dec 2010 | - | $120.37 M(-1.1%) |
| Sept 2010 | - | $121.77 M(+6.0%) |
| June 2010 | - | $114.83 M(-3.2%) |
| Mar 2010 | $118.58 M(+4.4%) | $118.58 M(+3.4%) |
| Dec 2009 | - | $114.73 M(-3.3%) |
| Sept 2009 | - | $118.67 M(+3.9%) |
| June 2009 | - | $114.16 M(+0.5%) |
| Mar 2009 | $113.60 M(-5.5%) | $113.60 M(-8.8%) |
| Dec 2008 | - | $124.58 M(+1.7%) |
| Sept 2008 | - | $122.50 M(-4.2%) |
| June 2008 | - | $127.93 M(+6.4%) |
| Mar 2008 | $120.25 M(+30.9%) | $120.25 M(+10.5%) |
| Dec 2007 | - | $108.81 M(+7.8%) |
| Sept 2007 | - | $100.90 M(+9.8%) |
| June 2007 | - | $91.92 M(+0.1%) |
| Mar 2007 | $91.83 M(+5.7%) | $91.83 M(+6.8%) |
| Dec 2006 | - | $85.99 M(+2.4%) |
| Sept 2006 | - | $84.00 M(-5.9%) |
| June 2006 | - | $89.28 M(+2.7%) |
| Mar 2006 | $86.90 M(+7.7%) | $86.90 M(+0.7%) |
| Dec 2005 | - | $86.26 M(+3.4%) |
| Sept 2005 | - | $83.41 M(-0.3%) |
| June 2005 | - | $83.63 M(+3.6%) |
| Mar 2005 | $80.72 M(-2.3%) | $80.72 M(-7.8%) |
| Dec 2004 | - | $87.58 M(+5.1%) |
| Sept 2004 | - | $83.35 M(-0.8%) |
| June 2004 | - | $84.05 M(+1.7%) |
| Mar 2004 | $82.64 M(+5.2%) | $82.64 M(-2.1%) |
| Dec 2003 | - | $84.40 M(+0.3%) |
| Sept 2003 | - | $84.16 M(-0.2%) |
| June 2003 | - | $84.33 M(+7.3%) |
| Mar 2003 | $78.58 M(+23.3%) | $78.58 M(-0.8%) |
| Dec 2002 | - | $79.20 M(+1.7%) |
| Sept 2002 | - | $77.84 M(+12.1%) |
| June 2002 | - | $69.42 M(+8.9%) |
| Mar 2002 | $63.74 M(+6.5%) | $63.74 M(-0.6%) |
| Dec 2001 | - | $64.11 M(-4.0%) |
| Sept 2001 | - | $66.80 M(+8.1%) |
| June 2001 | - | $61.80 M(+3.3%) |
| Mar 2001 | $59.84 M(+1.2%) | $59.84 M(+1.2%) |
| Mar 2000 | $59.14 M | $59.14 M |
FAQ
- What is Haemonetics annual accounts receivable?
- What is the all time high annual accounts receivable for Haemonetics?
- What is Haemonetics annual accounts receivable year-on-year change?
- What is Haemonetics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Haemonetics?
- What is Haemonetics quarterly accounts receivable year-on-year change?
What is Haemonetics annual accounts receivable?
The current annual accounts receivable of HAE is $206.56 M
What is the all time high annual accounts receivable for Haemonetics?
Haemonetics all-time high annual accounts receivable is $206.56 M
What is Haemonetics annual accounts receivable year-on-year change?
Over the past year, HAE annual accounts receivable has changed by +$27.42 M (+15.31%)
What is Haemonetics quarterly accounts receivable?
The current quarterly accounts receivable of HAE is $213.53 M
What is the all time high quarterly accounts receivable for Haemonetics?
Haemonetics all-time high quarterly accounts receivable is $213.53 M
What is Haemonetics quarterly accounts receivable year-on-year change?
Over the past year, HAE quarterly accounts receivable has changed by +$39.28 M (+22.55%)